Driehaus Capital Management LLC Gilead Sciences, Inc. Transaction History

Driehaus Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $184,127 - $208,805	2,513 New	2,513 $203,000
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $199,476 - $249,965	-3,444 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $223,446 - $253,616	3,444 New	3,444 $250,000
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $2.26 Million - $2.63 Million	-31,300 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $1.96 Million - $2.51 Million	31,300 New	31,300 $2.34 Million

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.